AirSculpt Technologies, Inc. AIRS R2K

Healthcare · Medical Care Facilities · United States

https://www.airsculpt.com

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

Market & Price

Market Cap

$379.54M

Current Price

$5.38

High / Low (52W)

$11.65 / $1.58

Beta

2.02

Valuation

Stock P/E

Industry PE

23.65

Forward P/E

PEG Ratio

Book Value

$1.42

Price to Book

3.79

P/S

2.50

EV/EBITDA

57.74

Dividend Yield

Profitability & Returns

ROCE

-7.25%

ROE

-12.63%

ROA

-1.60%

Profit Margin

-7.39%

Op Margin

-4.58%

EPS (Latest Qtr)

$-0.03

EPS (TTM)

$-0.17

Balance Sheet & Liquidity

Debt/Equity

0.71

Quick Ratio

0.57

Current Ratio

0.75

Debt

$71.02M

Total Assets

$187.30M

Current Assets

$15.46M

Working Capital

$-12.45M

Ownership

Promoter Holding

43.06%

Chg in Prom Hold

0.43%

FII / Inst Holding

66.04%

Chg in FII Hold

0.00%

Financial Snapshot

Enterprise Value

$433.86M

Total Revenue (TTM)

$151.84M

EBITDA

$7.51M

Free Cash Flow

$13.02M

Operating Cash Flow

$7.50M

Shares Outstanding

70.55M

Gross Margin

66.06%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

-3.47%

Profit 5Y

6.84%

Revenue (YoY)

0.00%

Earnings (YoY)

PROS

Generates positive free cash flow.

CONS

Revenue declined at -3.5% CAGR over 5 years.
Trading 53.8% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).
RSI at 75 suggests overbought conditions.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	AIRS AirSculpt Technologies, Inc. R2K	5.38	-	$379.54M	-	-7.25%	-12.63%	-3.47%	6.84%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	26.14M	34.97M	34.65M	-	39.54M	49.65M	38.89M	45.81M	55.70M	46.79M	47.62M	51.00M	-	-	39.37M	44.01M	34.99M	33.44M	39.39M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15.95M	17.20M	14.86M	13.68M	15.59M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	23.42M	26.81M	20.13M	19.77M	23.80M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25.01M	25.92M	22.74M	21.29M	25.60M
Operating Income	7.21M	11.20M	9.62M	-	-1.17M	3.96M	-1.38M	1.76M	5.36M	955.00K	11.01M	-4.98M	-	-	-1.59M	894.00K	-2.61M	-1.52M	-1.80M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.65M	4.03M	-6.53M	2.07M	1.36M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.62M	1.56M	1.41M	1.48M	1.20M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3.21M	-776.00K	-11.16M	-2.49M	-2.86M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-367.00K	-185.00K	-1.65M	-3.77M	-465.00K
Net Income	6.62M	10.03M	8.05M	-393.00K	-693.00K	583.00K	-7.38M	-14.00K	1.78M	-1.67M	6.03M	-3.21M	-	-	-2.85M	-591.00K	-9.51M	1.28M	-2.40M
Diluted EPS	-	-	-	-	-0.01	0.01	-0.13	0.00	0.03	-0.03	0.10	-0.06	-	-	-0.05	-0.01	-0.15	0.02	-0.03

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	41.24M	62.77M	-	168.79M	195.92M	180.35M	151.82M
Cost of Revenue	-	-	-	62.78M	73.77M	71.15M	61.69M
Gross Profit	-	-	-	106.01M	122.14M	109.20M	90.13M
Operating Expenses	-	-	-	109.48M	112.63M	110.77M	94.96M
Operating Income	663.00K	10.03M	-	-3.47M	9.51M	-1.57M	-4.83M
EBITDA	-	-	-	3.52M	19.98M	10.30M	1.22M
Interest Expense	-	-	-	6.75M	6.49M	6.25M	6.08M
Pretax Income	-	-	-	-11.30M	3.24M	-7.83M	-17.64M
Tax Provision	-	-	-	3.38M	7.48M	188.00K	-5.97M
Net Income	-2.21M	7.58M	-	-14.68M	-4.24M	-8.02M	-11.67M
Diluted EPS	-	-	-	-0.26	-0.08	-0.14	-0.19

Compounded Sales Growth

5 Years:	-3.47%
1 Year:	0.00%

Compounded Profit Growth

5 Years:	6.84%
1 Year:	-

Stock Price Performance

1 Year:	+22.00%
6 Months:	+38.66%
3 Months:	+240.51%
1 Month:	+111.81%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	179.61M	-	200.76M	204.02M	212.78M	187.30M
Current Assets	-	-	16.68M	15.96M	17.12M	15.46M
Cash & Equivalents	10.38M	-	9.62M	10.26M	8.23M	8.45M
Inventory	-	-	-	-	-	-
Receivables	-	-	2.83M	1.94M	3.06M	1.50M
Total Liabilities	55.93M	-	129.99M	120.03M	134.59M	99.59M
Current Liabilities	9.46M	-	22.32M	20.32M	28.95M	27.90M
Long Term Debt	32.12M	-	81.42M	69.50M	70.46M	50.59M
Total Debt	-	-	107.65M	99.67M	108.94M	83.57M
Total Equity	-	-	70.77M	83.99M	78.19M	87.71M
Shares Outstanding	-	-	56.18M	57.36M	58.37M	64.54M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	4.94M	13.96M	-	24.45M	23.96M	11.35M	3.10M
Investing Cash Flow	-4.44M	-3.69M	-	-12.92M	-9.92M	-14.01M	-2.40M
Financing Cash Flow	-783.00K	-5.02M	-	-27.26M	-13.39M	630.00K	-478.00K
Capital Expenditure	-4.44M	-3.69M	-	-12.92M	-9.92M	-14.01M	-2.40M
Free Cash Flow	499.00K	10.27M	-	11.53M	14.04M	-2.66M	692.00K
Net Change in Cash	-	-	-	-15.73M	646.00K	-2.03M	214.00K
Dividends Paid	-	0	0	23.16M	385.00K	252.00K	0

Ratios (Annual)

Figures in %.

Metric	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	62.8%	62.3%	60.5%	59.4%
Operating Margin %	1.6%	16.0%	-	-2.1%	4.9%	-0.9%	-3.2%
Net Margin %	-5.4%	12.1%	-	-8.7%	-2.2%	-4.4%	-7.7%
ROE %	-	-	-	-20.7%	-5.0%	-10.3%	-13.3%
ROCE %	-	5.9%	-	-1.9%	5.2%	-0.9%	-3.0%

Shareholding Pattern

Insiders

43.06%

Institutions

66.04%

Public Float

115.99%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Vesey Street Capital Partners, LLC	42.99%	30.32M	$163.14M
2	Balyasny Asset Management LP	3.30%	2.33M	$12.52M
3	FourWorld Capital Management, LLC	1.40%	987.76K	$5.31M
4	Blackrock Inc.	1.14%	804.08K	$4.33M
5	Wexford Capital LP	0.95%	670.52K	$3.61M
6	UBS Group AG	0.88%	622.29K	$3.35M
7	Susquehanna International Group, LLP	0.67%	474.44K	$2.55M
8	Geode Capital Management, LLC	0.52%	368.46K	$1.98M
9	Saba Capital Management, L.P.	0.44%	313.04K	$1.68M
10	AQR Capital Management, LLC	0.44%	309.33K	$1.66M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for AIRS

No recent headlines available.

AIRS · Healthcare